Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7649b77c98cdca3647fe825abf0b4402 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2005-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c7cf091724736c1112967dbbbe89a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a7fd84853a56adfb3fb2d19774b4c5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_621bc11f8b87866fc1394cbc07c3ed5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d559fa3683abea12f97dc212ea5ddd39 |
publicationDate |
2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1718336-B1 |
titleOfInvention |
Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases |
abstract |
The present invention describes a combination of anticholinergic and β mimetics for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma. It further comprises the preparation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703806-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9415009-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471468-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10716753-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815258-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9463161-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8808713-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8324266-B2 |
priorityDate |
2004-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |